Literature DB >> 3012016

Noxiustoxin, a short-chain toxin from the Mexican scorpion Centruroides noxius, induces transmitter release by blocking K+ permeability.

M Sitges, L D Possani, A Bayón.   

Abstract

Noxiustoxin (NTX), a 39 amino acid peptide purified from the venom of the Mexican scorpion Centruroides noxius, has been shown to block voltage-dependent K+ currents in the squid giant axon (Possani et al., 1982; Carbone et al., 1982). Although several other drugs known as K+ channel blockers in the squid axon also act on isolated nerve terminals to produce an increase in transmitter release, these releasing effects have not been shown to be related to a decrease of K+ permeability in synaptosomes (Vizi et al., 1977; Tapia and Sitges, 1982). In this work we show that NTX increases 3H-GABA release from perfused mouse brain synaptosomes. This effect was not blocked by TTX. Ca2+ channel blockers (verapamil or Co2+) or the absence of external Ca2+ prevents the releasing effect of this toxin. NTX does not seem to induce transmitter release by directly increasing Ca2+ permeability: The K+ ionophore valinomycin completely inhibits the release induced by NTX, as well as that evoked by the K+ channel blocker 4-aminopyridine; in contrast, the release evoked by a Ca2+ ionophore is not blocked by valinomycin. These findings strongly suggest that the releasing effect of NTX is mediated by a decrease in K+ permeability. External Ca2+ is needed only in order to couple this stimulus with the release process. Consistent with this hypothesis, we present evidence that NTX blocks the efflux of 86Rb+ from synaptosomes. An extended comparison of the effect of 4-aminopyridine with that of NTX is also reported.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3012016      PMCID: PMC6568734     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  9 in total

Review 1.  Use of toxins to study potassium channels.

Authors:  M L Garcia; A Galvez; M Garcia-Calvo; V F King; J Vazquez; G J Kaczorowski
Journal:  J Bioenerg Biomembr       Date:  1991-08       Impact factor: 2.945

Review 2.  An emerging pharmacology of peptide toxins targeted against potassium channels.

Authors:  E Moczydlowski; K Lucchesi; A Ravindran
Journal:  J Membr Biol       Date:  1988-10       Impact factor: 1.843

3.  A new type of scorpion Na+-channel-toxin-like polypeptide active on K+ channels.

Authors:  Najet Srairi-Abid; Joseba Iñaki Guijarro; Rym Benkhalifa; Massimo Mantegazza; Amani Cheikh; Manel Ben Aissa; Pierre-Yves Haumont; Muriel Delepierre; Mohamed El Ayeb
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

4.  Nigericin-induced Na+/H+ and K+/H+ exchange in synaptosomes: effect on [3H]GABA release.

Authors:  R Rodríguez; M Sitges
Journal:  Neurochem Res       Date:  1996-08       Impact factor: 3.996

5.  Characterization of the participation of sodium channels on the rise in Na+ induced by 4-aminopyridine (4-AP) in synaptosomes.

Authors:  Emilio Galván; María Sitges
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

6.  Characterization of the type of calcium channel primarily regulating GABA exocytosis from brain nerve endings.

Authors:  M Sitges; L M Chiu
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

7.  Synthetic peptides corresponding to the sequence of noxiustoxin indicate that the active site of this K+ channel blocker is located on its amino-terminal portion.

Authors:  G B Gurrola; R Molinar-Rode; M Sitges; A Bayon; L D Possani
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

8.  Towards therapeutic applications of arthropod venom k(+)-channel blockers in CNS neurologic diseases involving memory acquisition and storage.

Authors:  Christiano D C Gati; Márcia R Mortari; Elisabeth F Schwartz
Journal:  J Toxicol       Date:  2012-06-04

Review 9.  Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond.

Authors:  Xiaoli Wang; Guoyi Li; Jingkang Guo; Zhiping Zhang; Shuzhang Zhang; Yudan Zhu; Jiwei Cheng; Lu Yu; Yonghua Ji; Jie Tao
Journal:  Front Neurosci       Date:  2020-01-14       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.